GlassScriptPhysician profile
Ali M Nasur
NPI 1922011782
$74,948.90
in general payments reported to CMS, 2019-2025
45 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,520 · 2021: $14K · 2022: $15K · 2023: $7,745 · 2024: $12K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $13K · Consulting Fee: $5,115 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,213.11 |
| Travel and Lodging | $13,013.67 |
| Consulting Fee | $5,115.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $31,395.61 | 2019-2025 | Indigo System, Ruby Coil, Penumbra Coil 400 |
| Biotronik INC. | $8,614.56 | 2019-2025 | Biomonitor, Amvia Edge, Selectra |
| Impulse Dynamics (USA) INC. | $8,367.18 | 2021-2025 | Optimizer, Optimizer |
| Cardiovascular Systems INC. | $7,130.25 | 2019-2022 | |
| Medtronic, INC. | $2,690.20 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Crome Dr Mri Surescan |
| Biosense Webster, INC. | $1,872.05 | 2020-2025 | Carto 3 |
| Ekos Corporation | $1,543.55 | 2019 | |
| Abiomed | $1,536.15 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,436.75 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Rhythmia Mapping System, General - Therapies |
| Bard Peripheral Vascular, INC. | $1,277.12 | 2021-2023 | Venclose Maven Catheter |
| Novartis Pharmaceuticals Corporation | $1,265.50 | 2019-2025 | |
| Nevro Corp. | $879.68 | 2024 | Senza |
| Philips North America LLC | $831.00 | 2021-2024 | (5153) Azurion 5 M20 Gc, (Dd1) Duo Hybrid |
| E.R. Squibb & Sons, L.L.C. | $659.92 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $624.54 | 2019-2025 | Jardiance |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $602.49 | 2019-2025 | Farxiga |
| Medtronic Vascular, INC. | $497.30 | 2019-2020 | |
| Pfizer INC. | $414.96 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $412.04 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Abbott Laboratories | $333.78 | 2019-2025 | Xience Skypoint, Perclose Prostyle, Cardiomems |
| Globus Medical, INC. | $317.67 | 2025 | Senza |
| Edwards Lifesciences Corporation | $286.70 | 2021-2025 | |
| Chiesi USA, INC. | $243.18 | 2019-2023 | Kengreal |
| Cordis US Corp. | $239.88 | 2022-2025 | Mynx Control, Mynx Control Venous, S.M.A.R.T. Control |
| Cardiva Medical, INC. | $227.61 | 2022-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $219.34 | 2019-2024 | Xarelto |
| Amgen INC. | $172.91 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $153.00 | 2025 | |
| Scpharmaceuticals INC. | $119.52 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.34 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $72.02 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.78 | 2022-2025 | Lifevest |
| Arbor Pharmaceuticals, INC. | $47.29 | 2019-2021 | |
| Angiodynamics, INC. | $46.30 | 2022-2025 | Alphavac |
| Esperion Therapeutics, INC. | $40.72 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $32.07 | 2025 | Opsumit, Uptravi |
| Xeris Pharmaceuticals, INC. | $31.96 | 2023-2025 | Keveyis |
| Stryker Corporation | $30.92 | 2025 | Flowtriever |
| Kiniksa Pharmaceuticals, LTD. | $23.78 | 2022 | |
| United Therapeutics Corporation | $20.75 | 2019 | |
| Cycle Pharmaceuticals INC | $19.49 | 2025 | Ormalvi |
| Inari Medical, INC. | $17.14 | 2022 | |
| Gilead Sciences, INC. | $12.65 | 2019 | |
| Altathera Pharmaceuticals LLC | $11.25 | 2021 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Nasur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.